Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 20,196 shares of RCKT stock, worth $176,311. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,196
Previous 12,006
68.22%
Holding current value
$176,311
Previous $221,000
14.48%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding RCKT
# of Institutions
243Shares Held
94.3MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$154 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$57.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$54.1 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$45.4 Million1.26% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.71MShares$41.2 Million0.27% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $661M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...